Journal profile · Medicine, Research & Experimental
Clinical Science
ISSN 0143-5221 · eISSN 1470-8736 · Portland Press Ltd. · ENGLAND · Monthly · Founded 1979
Clinical Science: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 7.21; hybrid open access; median 144 days to acceptance (101 articles, last 24 months); community-reported acceptance: moderate; 98 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Science is published by Portland Press Ltd. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Heart Rate Variability and Autonomic Control, Nitric Oxide and Endothelin Effects and Cardiovascular and exercise physiology, together about 19.8% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine and Physiology. (generated from OpenAlex topic counts and CAS ranking data)
Translating molecular bioscience and experimental research into medical insights, Clinical Science offers multi-disciplinary coverage and clinical perspectives to advance human health.
From the journal's Aims & Scope
Research area (LetPub): Medicine, Research & Experimental
Editor-in-chief Michael J. RyanPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Heart Rate Variability and Autonomic ControlMedicine7.9%
- Nitric Oxide and Endothelin EffectsMedicine6.4%
- Cardiovascular and exercise physiologyMedicine5.5%
- Diet and metabolism studiesMedicine5.4%
- Hormonal Regulation and HypertensionMedicine5.2%
- Renin-Angiotensin System StudiesMedicine4.9%
- Blood Pressure and Hypertension StudiesMedicine4.7%
- Liver Disease Diagnosis and TreatmentMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.21LetPub ·
- CiteScore 2026-06
- 11.7LetPub ·
- SJR 2026-06
- 2.09LetPub ·
- SNIP 2026-06
- 1.59LetPub ·
- h-index
- 126LetPub ·
- h-index
- 214OpenAlex ·
- i10-index
- 6,626OpenAlex ·
- 2-year mean citedness
- 5.05OpenAlex ·
- Self-citation rate
- 1.4%LetPub ·
- Share of gold OA articles
- 86.91%LetPub ·
Volume
- Articles per year
- 93LetPub ·
Articles by year OpenAlex count · 11,100 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 133 | 116 | 62 |
| 2025 | 98 | 98 | 538 |
| 2024 | 103 | 95 | 1,087 |
| 2023 | 109 | 96 | 2,539 |
| 2022 | 115 | 89 | 3,678 |
| 2021 | 171 | 137 | 5,447 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
144 daysMedian, submission to acceptance · P25–P75 96 days – 197 days
- Acceptance to online
- median 0 days (13 articles)
- Submission to online
- median 126 days
- Sample
- 101 articles with submission and acceptance dates (268 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access articles
IRAP deficiency preserves renal function and attenuates pathology in aged mice Expression of Concern: Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors Histone demethylase Kdm2a aggravates pressure overload-induced myocardial fibrosis through global and locus-specific H3K36me2 chromatin remodeling Interferon-λ Receptor Positive Monocytes/Macrophages Orchestrate a Pro…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Portland Press Ltd.
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1979
- ISSN
- 0143-5221
- Electronic ISSN
- 1470-8736
- Latest issue on the website
- Volume 140, Issue 10 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Clinical Science
What CAS zone is Clinical Science in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Science is in Zone 2 of Medicine, and in Zone 2 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Science?
The latest impact factor listed by LetPub is 7.21; CiteScore 11.7, h-index 214.
How long does peer review take at Clinical Science?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 144 days (interquartile range 96–197 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Clinical Science?
According to LetPub and DOAJ records, Clinical Science is indexed in SCIE and Scopus.
Is Clinical Science open access, and what is the APC?
Clinical Science is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .